Glycogen Synthase Kinase-3β (GSK-3β) Inhibition Enhances Dendritic Cell-based Cancer Vaccine Potency via Suppression of Interferon-γ-induced Indoleamine 2,3-Dioxygenase Expression (Q35583214)
Jump to navigation
Jump to search
scientific article published on 26 March 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Glycogen Synthase Kinase-3β (GSK-3β) Inhibition Enhances Dendritic Cell-based Cancer Vaccine Potency via Suppression of Interferon-γ-induced Indoleamine 2,3-Dioxygenase Expression |
scientific article published on 26 March 2015 |
Statements
1 reference
Glycogen Synthase Kinase-3β (GSK-3β) Inhibition Enhances Dendritic Cell-based Cancer Vaccine Potency via Suppression of Interferon-γ-induced Indoleamine 2,3-Dioxygenase Expression (English)
1 reference
Kyung Tae Noh
1 reference
Kwang Hee Son
1 reference
In Duk Jung
1 reference
Tae Heung Kang
1 reference
Chang Hun Choi
1 reference
Yeong-Min Park
1 reference
26 March 2015
1 reference
1 reference
290
1 reference
19
1 reference
12394-12402
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference